Yayın:
Multiple myeloma kidney

dc.contributor.authorAyar, Yavuz
dc.contributor.authorErsoy, Alparslan
dc.contributor.authorYıldız, Abdülmecit
dc.contributor.buuauthorAyar, Yavuz
dc.contributor.buuauthorERSOY, ALPARSLAN
dc.contributor.buuauthorYILDIZ, ABDULMECİT
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentNefroloji Ana Bilim Dalı
dc.contributor.orcid0000-0003-4607-9220
dc.contributor.researcheridAAH-5054-2021
dc.contributor.researcheridAGF-0767-2022
dc.contributor.researcheridGSE-0029-2022
dc.contributor.researcheridO-9948-2015
dc.date.accessioned2024-10-07T13:35:55Z
dc.date.available2024-10-07T13:35:55Z
dc.date.issued2015-01-01
dc.description.abstractKidney injury is a common complication of symptomatic multiple myeloma (MM) and has an impact on the survival of patients. Cast nephropathy (myeloma kidney) is the most common cause of severe kidney dysfunction in MM. Hypercalcemia, hyperuricemia, volume depletion, usage of nephrotoxic agents and radiocontrast are the other non-myeloma specific reasons for kidney injury. Recent advances in chemotherapeutic agents, stem cell transplantation, plasma exchange and dialysis techniques seem to improve survival of MM and the prognosis of myeloma-associated kidney injury. However, responsiveness to treatment differs considerably among patients because of the high heterogeneity of myeloma. Herein, we review different forms of renal involvement and current therapeutic approaches in patients with myeloma.
dc.identifier.doi10.5262/tndt.2015.1003.02
dc.identifier.endpage265
dc.identifier.issn1300-7718
dc.identifier.issue3
dc.identifier.startpage256
dc.identifier.urihttps://doi.org/10.5262/tndt.2015.1003.02
dc.identifier.urihttps://turkjnephrol.org/en/multiple-myeloma-kidney-135777
dc.identifier.urihttps://hdl.handle.net/11452/46008
dc.identifier.volume24
dc.identifier.wos000374928400003
dc.indexed.wosWOS.ESCI
dc.language.isoen
dc.publisherTürk Nefroloji Diyaliz Transplantasyon Dergisi
dc.relation.journalTurkish Nephrology Dialysis and Transplantation Journal
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectStage renal-disease
dc.subjectChain deposition disease
dc.subjectClinical-features
dc.subjectCast nephropathy
dc.subjectPlasma-exchange
dc.subjectFollow-up
dc.subjectInjury
dc.subjectDiagnosis
dc.subjectTransplantation
dc.subjectFailure
dc.subjectMultiple myeloma
dc.subjectKidney involvement
dc.subjectTreatment
dc.subjectTransplantation
dc.subjectUrology & nephrology
dc.titleMultiple myeloma kidney
dc.typeReview
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/Nefroloji Ana Bilim Dalı
local.indexed.atWOS
relation.isAuthorOfPublication3b0ea0d7-f953-4c53-9e92-e260b04f90b4
relation.isAuthorOfPublicatione0f20ddb-a439-4c4a-b87e-d468370abf60
relation.isAuthorOfPublication.latestForDiscovery3b0ea0d7-f953-4c53-9e92-e260b04f90b4

Dosyalar